4.7 Article

Candida auris in Healthcare Facilities, New York, USA, 2013-2017

Journal

EMERGING INFECTIOUS DISEASES
Volume 24, Issue 10, Pages 1816-1824

Publisher

CENTERS DISEASE CONTROL
DOI: 10.3201/eid2410.180649

Keywords

-

Funding

  1. Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement [NU50CK000423, CK000423-01S2]
  2. CDC

Ask authors/readers for more resources

Candida auris is an emerging yeast that causes healthcare-associated infections. It can be misidentified by laboratories and often is resistant to antifungal medications. We describe an outbreak of C. auris infections in healthcare facilities in New York City, New York, USA. The investigation included laboratory surveillance, record reviews, site visits, contact tracing with cultures, and environmental sampling. We identified 51 clinical case-patients and 61 screening case-patients. Epidemiologic links indicated a large, inter-connected web of affected healthcare facilities throughout New York City. Of the 51 clinical case-patients, 23 (45%) died within 90 days and isolates were resistant to fluconazole for 50 (98%). Of screening cultures performed for 572 persons (1,136 total cultures), results were C. auris positive for 61 (11%) persons. Environmental cultures were positive for samples from 15 of 20 facilities. Colonization was frequently identified during contact investigations; environmental contamination was also common.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available